Home › Researcher directory › David Collister
David Collister
Affiliation : University of Alberta · Population Health Research Institute · Canadian VIGOUR Centre · Hamilton Health Sciences · McMaster University
- 2Publications (affiliation in Canada)
- 142Total publications
- 2222Citations
- 27h-index
Research profile
David Collister has 2 indexed publications (2025–2026). Their work appears mainly in “American Journal of Nephrology” and “medRxiv”. Their most cited article, “Statistical Analysis Plan for the Treatment of Cardiovascular disease with low dose Rivaroxaban in Advanced CKD (TRACK) trial” (2025), has been cited 2 times. Their work is co-authored with at least 3 researchers.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsResearch areas
- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
- LGBTQ Health, Identity, and Policy
- Acute Kidney Injury Research
- Renal Diseases and Glomerulopathies
Publications (2)
- Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial
- Statistical Analysis Plan for the Treatment of Cardiovascular disease with low dose Rivaroxaban in Advanced CKD (TRACK) trial
Publication venues
- American Journal of Nephrology × 1
- medRxiv × 1
Publications per year
- 20261
- 20251
Collaborations
Partner institutions : Western University · London Health Sciences Centre · London Health Sciences Centre Research Institute
Co-authors
Bibliographic data from OpenAlex (open database).
Why choose Dzcademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.